Article
SARS-CoV-2 in an immunocompromised host: convalescent plasma therapy and viral evolution elucidated by whole genome sequencing.
BMJ case reports - 9 Dec 2023
Seth-Smith Helena, Vesenbeckh Silvan, Egli Adrian, Ott Sebastian
Abstract excerpt
The evolution of SARS-CoV-2 within immunocompromised hosts who fail to clear the virus over many months has been proposed as a route to the development of Variants of Concern (VoCs). We present a case of an immunocompromised male patient with a prolonged SARS-CoV-2 infection. During hospitalisation, 7 weeks after first diagnosis, his condition worsened to require continuous ventilation support. Resolution of...
Topics
- Humans
- Male
- SARS-CoV-2
- COVID-19
- COVID-19 Serotherapy
- Immunization, Passive
- Whole Genome Sequencing
- Immunocompromised Host
- Mutation
- Genome, Viral
